BioPharma Resources

Drugs by condition

Drugs approved for migraine

Brand-name prescription drugs and biologics whose FDA label lists migraine as an approved use. Matched on the label phrases: "migraine".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

36

Still marketed, NDA or BLA

Drug classes

6

Novel drugs

13

New molecular entities and new biologics

In development

8

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for migraine.

  • Brekiya (Autoinjector) (Dihydroergotamine Mesylate) · Amneal May 14, 2025
  • Atzumi (Dihydroergotamine Mesylate) · Satsuma Pharms Apr 30, 2025
  • Symbravo (Meloxicam, Rizatriptan Benzoate) · Axsome Jan 30, 2025
  • Rizafilm (Rizatriptan Benzoate) · Gensco Apr 14, 2023
  • Zavzpret (Zavegepant Hydrochloride) · Pfizer NovelMar 9, 2023

All approved drugs for migraine, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 164 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Serotonin-1b and Serotonin-1d Receptor Agonist (3)

  • Tosymra Sumatriptan · Tonix Meds · 2019
  • Zomig Zolmitriptan · Amneal · 2003
  • Imitrex Sumatriptan · Glaxosmithkline · 1997

Calcitonin Gene-related Peptide Receptor Antagonist (2)

  • Qulipta Atogepant · Abbvie · 2021
  • Ubrelvy Ubrogepant · Abbvie · 2019

Nonsteroidal Anti-inflammatory Drug (2)

  • Symbravo Meloxicam, Rizatriptan Benzoate · Axsome · 2025
  • Elyxyb Celecoxib · Scilex Pharms · 2020

Calcitonin Gene-related Peptide Antagonist (1)

  • Vyepti Eptinezumab-Jjmr · Lundbeck Seattle Biopharmaceuticals, Inc. · 2020

Acetylcholine Release Inhibitor (1)

Class not listed in FDA's data (27)

  • Zavzpret Zavegepant Hydrochloride · Pfizer · 2023
  • Nurtec Odt Rimegepant Sulfate · Pfizer · 2020
  • Emgality Galcanezumab-Gnlm · Eli Lilly and CO · 2018
  • Ajovy Fremanezumab-Vfrm · Teva Pharms USA · 2018
  • Aimovig Erenumab-Aooe · Amgen INC · 2018
  • Relpax Eletriptan Hydrobromide · Upjohn · 2002
  • Maxalt Rizatriptan Benzoate · Organon LLC · 1998
  • Topamax Topiramate · Janssen Pharms · 1996
  • Imitrex Statdose (Autoinjector) Sumatriptan Succinate · Glaxosmithkline · 1992
  • Brekiya (Autoinjector) Dihydroergotamine Mesylate · Amneal · 2025
  • Atzumi Dihydroergotamine Mesylate · Satsuma Pharms · 2025
  • Rizafilm Rizatriptan Benzoate · Gensco · 2023
  • Eprontia Topiramate · Azurity · 2021
  • Trudhesa Dihydroergotamine Mesylate · Impel Pharms · 2021
  • Zembrace Symtouch (Autoinjector) Sumatriptan Succinate · Tonix Meds · 2016
  • Qudexy Xr Topiramate · Upsher Smith Labs · 2014
  • Trokendi Xr Topiramate · Supernus Pharms · 2013
  • Cambia Diclofenac Potassium · Cosette · 2009
  • Treximet Naproxen Sodium, Sumatriptan Succinate · Azurity · 2008
  • Depakote Er Divalproex Sodium · Abbvie · 2000
  • Topamax Sprinkle Topiramate · Janssen Pharms · 1998
  • Maxalt-Mlt Rizatriptan Benzoate · Organon · 1998
  • Migranal Dihydroergotamine Mesylate · Bausch · 1997
  • Imitrex Sumatriptan Succinate · Glaxosmithkline · 1995
  • Depakote Divalproex Sodium · Abbvie · 1989
  • Inderal La Propranolol Hydrochloride · Ani Pharms · 1983
  • Depakote Divalproex Sodium · Abbvie · 1983

Drugs in development for migraine

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • CorabotaseIPN10200Phase 37 trials

    Ipsen · Moderate to Severe Glabellar Lines, Spasticity, Moderate to Severe Upper Facial Lines

  • BR005-036CPhase 32 trials

    Brise Pharmaceuticals Co., Ltd. · Migraine, With or Without Aura

  • AXS-07meloxicam-rizatriptanPhase 31 trial

    Axsome Therapeutics, Inc. · Migraine

  • EVO756Phase 24 trials

    Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis

  • BHV-2100Phase 21 trial

    Biohaven Therapeutics Ltd. · Migraine

  • MEDI0618Phase 21 trial

    AbbVie · Migraine

  • MTX101Phase 21 trial

    Manistee Therapeutics · Migraine

  • PRT-064040Phase 21 trial

    Sichuan Purity Pharmaceutical Technology Co., Ltd. · Migraine

1 discontinued brand-name drugs whose label still names it

More on migraine: recruiting trials · published research

Related in neurology: Alzheimer's disease · Parkinson's disease · Multiple sclerosis · Epilepsy and seizures · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Spinal muscular atrophy · Duchenne muscular dystrophy · Huntington's disease chorea · Tardive dyskinesia

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.